Founding Team

Nicole Baker, PhD
​
CEO
Immunologist and Pharmacovigilance Professional with extensive knowledge in global legislation and guidelines for Medical Affairs, Regulatory Affairs, Pharmacovigilance and Clinical Trials, gained by leading and managing global, multi-disciplinary teams. Overall 20 years’ experience gained within Academia, Pharmaceutical Industry, Regulatory Authority, Clinical Research Organisation and Start-up.

Bruno Ohana, PhD
​
CTO
Technologist and Engineering Leader with broad industry experience spanning a career of over 20 years, having performed senior engineering/engineering management roles across various industries from Cloud Infrastructure, Fintech, and AI in Healthcare.

Sean Murphy
​
CFO
Professional investment banking; 15 years in London. Serial entrepreneur with operational start-up experience and three successful exits. Skilled in international business development.
Get in Touch
Contact us to learn more about how we use artificial intelligence to deliver faster, accurate and high quality literature screening for drug safety.